Broadleaf Co., Ltd.
Broadleaf Co., Ltd. (BRDLF) Financial Performance & Income Statement Overview
Analyze Broadleaf Co., Ltd. (BRDLF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Broadleaf Co., Ltd. (BRDLF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Broadleaf Co., Ltd. BRDLF financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $4.76B | $5.09B | $4.54B | $4.41B |
Cost of Revenue | $1.64B | $1.78B | $1.59B | $1.55B |
Gross Profit | $3.12B | $3.30B | $2.95B | $2.85B |
Gross Profit Ratio | $0.66 | $0.65 | $0.65 | $0.65 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $2.76B | $2.94B | $2.62B | $2.83B |
Operating Expenses | $2.76B | $2.92B | $2.62B | $2.79B |
Total Costs & Expenses | $4.40B | $4.70B | $4.21B | $4.34B |
Interest Income | $7.56M | $0.00 | $0.00 | $11.66M |
Interest Expense | $51.06M | $18.50M | $0.00 | $16.05M |
Depreciation & Amortization | $810.64M | $781.08M | $732.18M | $710.04M |
EBITDA | $1.17B | $1.17B | $1.06B | $784.35M |
EBITDA Ratio | $0.25 | $0.23 | $0.23 | $0.18 |
Operating Income | $361.76M | $386.28M | $331.43M | $65.87M |
Operating Income Ratio | $0.08 | $0.08 | $0.07 | $0.01 |
Other Income/Expenses (Net) | -$52.49M | -$14.33M | -$54.83M | -$7.62M |
Income Before Tax | $309.27M | $371.95M | $276.59M | $58.25M |
Income Before Tax Ratio | $0.06 | $0.07 | $0.06 | $0.01 |
Income Tax Expense | $104.98M | $72.67M | $105.52M | $40.05M |
Net Income | $196.22M | $182.48M | $174.41M | $21.44M |
Net Income Ratio | $0.04 | $0.04 | $0.04 | $0.005 |
EPS | $2.19 | $1.98 | $1.88 | $0.24 |
Diluted EPS | $2.13 | $1.98 | $1.88 | $0.23 |
Weighted Avg Shares Outstanding | $89.45M | $92.12M | $89.21M | $89.33M |
Weighted Avg Shares Outstanding (Diluted) | $92.12M | $92.17M | $91.19M | $91.76M |
Over the last four quarters, Broadleaf Co., Ltd. achieved steady financial progress, growing revenue from $4.41B in Q2 2024 to $4.76B in Q1 2025. Gross profit stayed firm with margins at 66% in Q1 2025 versus 65% in Q2 2024. Operating income totaled $361.76M in Q1 2025, maintaining a 8% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $1.17B. Net income rose to $196.22M, with EPS at $2.19. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan